Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 13 of 98, showing 5 Applications out of 486 total, starting on record 61, ending on 65

# Protocol No Study Title Investigator(s) & Site(s)

61.

ECCT/23/12/03   CONSTELLATION
    A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the effect of Bi-26 (strain of Bifidobacterium longum, B. infantis) supplementation versus placebo on weight gain in underweight infants   
Principal Investigator(s)
1. Dr Benson Ochieng Singa
Site(s) in Kenya
1. Migori County Referral Hospital (Migori county)
 
View

62.

ECCT/23/10/06   CONSTELLATION
    A Phase 3, randomized, double-blind, placebo-controlled study to evaluate the effect of Bi-26 (strain of Bifidobacterium longum, B. infantis) supplementation versus placebo on weight gain in underweight infants   
Principal Investigator(s)
1. Dr Godfrey Allan Otieno
2. Dr Videlis Nduba
Site(s) in Kenya
1. KEMRI-Kondele Children’s Hospital (Kisumu county)
2. KEMRI CRDR Clinical Research Annex (Nairobi City county)
 
View

63.

ECCT/23/09/04   GBT440-038Open-Label Extension
    An Open-Label Extension Study of Voxelotor Administered Orally to Participants with Sickle Cell Disease Who Have Participated in Voxelotor Clinical Trials       
Principal Investigator(s)
1. Jessie Nyokabi Githanga
2. Videlis Nduba
3. Bernhards Ragama Ogutu
Site(s) in Kenya
1. Gertrude’s Children Hospital (Nairobi City county)
2. Kenya Medical Research Institute (KEMRI), Centre for Respiratory Diseases Research (CRDR) (Nairobi City county)
3. KEMRI CRDR SIAYA within Siaya County Referral Hospital Grounds (Siaya county)
4. Strathmore University Medical Center, Centre for Research in Therapeutic Sciences (Nairobi City county)
 
View

64.

ECCT/23/10/03   PEARL RSVt Vaccine Study
    Phase III, randomized, observer-blind, placebo-controlled, multi-center, multinational study to evaluate the efficacy, immunogenicity, and safety of a Respiratory Syncytial Virus vaccine in infants and toddlers (PEARL)   
Principal Investigator(s)
1. Dr. Lucas Tina, Otieno
2. Prof. Kariuki Simon
3. Dr. Janet Nyawira Oyieko
4. Walter Otieno
5. Onono Dr. Marciana
6. Prof. Walter Jaoko
7. Dr Fredrick Sawe
Site(s) in Kenya
1. Victoria Biomedical Research Institute (VIBRI) (Kisumu county)
2. Walter Reed Army Institute of Research -Kericho Site (Kericho county)
3. KEMRI CCR – Butere Clinical Research Centre (Kakamega county)
4. Siaya County Referral Hospital (SCRH (Siaya county)
5. Kenya Medical Research Institute Center for Microbiology Research (CMR (Kisumu county)
6. KAVI - Institute of Clinical Research (KAVI - ICR) (Nairobi City county)
7. Kombewa Clinical Research Center, KEMRI, (Kisumu county)
 
View

65.

ECCT/23/10/02   MATRIX-001 protocol
    A Phase I Randomized, Placebo-Controlled, Double-Blind Study to Assess Safety, Pharmacokinetics, and Modeled Pharmacodynamics of a Vaginal Insert Containing Tenofovir Alafenamide and Elvitegravir       
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
KEMRI-CCR PHRD Thika
 
View